Tags |
|
|
Links |
|
|
E-Folder - Will eMiniMalls Go the Way of Tivo -- or Replay?
Did you ever hear of Replay TV? They started up at about the same time as TiVo and did pretty much the same thing
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
: they developed a personal video recorder that stores television shows on a hard drive. Whenever both companies
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
ppeared at tech shows, critics would rave about Replay’s technology and turn their noses up at TiVo’s.
Replay di
Replay di
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
d just as TiVo hit the big time.
So if Replay had such a great product, what went wrong? Well, it seems to be th
So if Replay had such a great product, what went wrong? Well, it seems to be th
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
same thing that’s going wrong with Chitika at the moment.
I still think that Chitika have a great product. Thei
I still think that Chitika have a great product. Thei
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
ads look good, they’re fun to mouse over, packed with information and they’re easy for publishers to control. I’
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
ve had some pretty impressive CTRs with them.
Like Replay, there’s nothing wrong with Chitika’s product. But the
Like Replay, there’s nothing wrong with Chitika’s product. But the
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
e seems to be plenty wrong with what’s happening on the business end of the company. First there was the audit th
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
t slashed everyone’s incomes. That came out of the blue, hit everyone right where it hurt and destroyed much of t
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
e trust and enthusiasm that had built up around the company’s eMiniMalls. Now there’s a delay in paying the resul
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
s of those same slashed November earnings -- and that delay wasn’t announced until after the payments should alre
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
ady have been made.
The people at Chitika are a pretty smart bunch and they went out of their way to make eMiniM
The people at Chitika are a pretty smart bunch and they went out of their way to make eMiniM
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
lls friendly to publishers. I don’t know how they messed up so badly or who’s responsible for it, but I sure hope
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
they going to get it fixed (although even if they do, I think they’re going to have to work pretty hard to win ba
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
k people’s trust.)
But I can’t imagine a product as good as eMiniMalls is just going to disappear. I’ve already
But I can’t imagine a product as good as eMiniMalls is just going to disappear. I’ve already
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
een traditional ads designed to look exactly like eMiniMalls on Web pages. They weren’t interactive and they look
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
ed too much like ads to be very effective but it’s pretty clear that ads like eMiniMalls can be a great way to ge
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
erate extra revenue. Users love them.
Even if Chitika don’t get their act together, I’m pretty confident that so
Even if Chitika don’t get their act together, I’m pretty confident that so
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
eone else will. I’m going to be keeping a close eye on Chitika to see if they can solve their problems... but I’m
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
also going to be watching out for other companies to see if they’re going to take advantage of Chitika’s big idea
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.e-folder.org.ua/article/72986/e-folder-Will-eMiniMalls-Go-the-Way-of-Tivo--or-Replay.html">Will eMiniMalls Go the Way of Tivo -- or Replay?</a>
BB link (for phorums):
[url=http://www.e-folder.org.ua/article/72986/e-folder-Will-eMiniMalls-Go-the-Way-of-Tivo--or-Replay.html]Will eMiniMalls Go the Way of Tivo -- or Replay?[/url]
Related Articles:
Quick Easy Ways To Get Your Prospects to Take Action Now
Is The Duplicate Content Penalty A Myth?
Make Money Online - So Many Possibilities
Bookmark it:
|